Your browser doesn't support javascript.
loading
Claudin-1 Binder Enhances Epidermal Permeability in a Human Keratinocyte Model.
Nakajima, Misaki; Nagase, Shotaro; Iida, Manami; Takeda, Shuji; Yamashita, Mayo; Watari, Akihiro; Shirasago, Yoshitaka; Fukasawa, Masayoshi; Takeda, Hiroyuki; Sawasaki, Tatsuya; Yagi, Kiyohito; Kondoh, Masuo.
Affiliation
  • Nakajima M; Laboratory of Bio-Functional Molecular Chemistry, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan (M.N., S.N., M.I., M.Y., A.W., K.Y., M.K.); Asubio Pharma Co., Ltd., Hyogo, Japan (S.T.); Department of Biochemistry and Cell Biology, National Institute of Infectious Disease
  • Nagase S; Laboratory of Bio-Functional Molecular Chemistry, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan (M.N., S.N., M.I., M.Y., A.W., K.Y., M.K.); Asubio Pharma Co., Ltd., Hyogo, Japan (S.T.); Department of Biochemistry and Cell Biology, National Institute of Infectious Disease
  • Iida M; Laboratory of Bio-Functional Molecular Chemistry, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan (M.N., S.N., M.I., M.Y., A.W., K.Y., M.K.); Asubio Pharma Co., Ltd., Hyogo, Japan (S.T.); Department of Biochemistry and Cell Biology, National Institute of Infectious Disease
  • Takeda S; Laboratory of Bio-Functional Molecular Chemistry, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan (M.N., S.N., M.I., M.Y., A.W., K.Y., M.K.); Asubio Pharma Co., Ltd., Hyogo, Japan (S.T.); Department of Biochemistry and Cell Biology, National Institute of Infectious Disease
  • Yamashita M; Laboratory of Bio-Functional Molecular Chemistry, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan (M.N., S.N., M.I., M.Y., A.W., K.Y., M.K.); Asubio Pharma Co., Ltd., Hyogo, Japan (S.T.); Department of Biochemistry and Cell Biology, National Institute of Infectious Disease
  • Watari A; Laboratory of Bio-Functional Molecular Chemistry, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan (M.N., S.N., M.I., M.Y., A.W., K.Y., M.K.); Asubio Pharma Co., Ltd., Hyogo, Japan (S.T.); Department of Biochemistry and Cell Biology, National Institute of Infectious Disease
  • Shirasago Y; Laboratory of Bio-Functional Molecular Chemistry, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan (M.N., S.N., M.I., M.Y., A.W., K.Y., M.K.); Asubio Pharma Co., Ltd., Hyogo, Japan (S.T.); Department of Biochemistry and Cell Biology, National Institute of Infectious Disease
  • Fukasawa M; Laboratory of Bio-Functional Molecular Chemistry, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan (M.N., S.N., M.I., M.Y., A.W., K.Y., M.K.); Asubio Pharma Co., Ltd., Hyogo, Japan (S.T.); Department of Biochemistry and Cell Biology, National Institute of Infectious Disease
  • Takeda H; Laboratory of Bio-Functional Molecular Chemistry, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan (M.N., S.N., M.I., M.Y., A.W., K.Y., M.K.); Asubio Pharma Co., Ltd., Hyogo, Japan (S.T.); Department of Biochemistry and Cell Biology, National Institute of Infectious Disease
  • Sawasaki T; Laboratory of Bio-Functional Molecular Chemistry, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan (M.N., S.N., M.I., M.Y., A.W., K.Y., M.K.); Asubio Pharma Co., Ltd., Hyogo, Japan (S.T.); Department of Biochemistry and Cell Biology, National Institute of Infectious Disease
  • Yagi K; Laboratory of Bio-Functional Molecular Chemistry, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan (M.N., S.N., M.I., M.Y., A.W., K.Y., M.K.); Asubio Pharma Co., Ltd., Hyogo, Japan (S.T.); Department of Biochemistry and Cell Biology, National Institute of Infectious Disease
  • Kondoh M; Laboratory of Bio-Functional Molecular Chemistry, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan (M.N., S.N., M.I., M.Y., A.W., K.Y., M.K.); Asubio Pharma Co., Ltd., Hyogo, Japan (S.T.); Department of Biochemistry and Cell Biology, National Institute of Infectious Disease
J Pharmacol Exp Ther ; 354(3): 440-7, 2015 Sep.
Article in En | MEDLINE | ID: mdl-26139628
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Protein Binding / Keratinocytes / Claudin-1 Type of study: Prognostic_studies Limits: Humans Language: En Year: 2015 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Protein Binding / Keratinocytes / Claudin-1 Type of study: Prognostic_studies Limits: Humans Language: En Year: 2015 Type: Article